NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma-Reference-Cited by-同舟云学术

NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma

Published:2014-06-12 Issue:9 Volume:11 Page:1497-1506
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Corradi Massimo,Chrystyn Henry,Cosio Borja G,Pirozynski Michal,Loukides Stelios,Louis Renaud,Spinola Monica,Usmani Omar S

Publisher

Informa Healthcare

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425247.2014.928282

Reference35 articles.

1. The Global Burden of Respiratory Disease

2. Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease

3. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure

4. History and future perspectives of treating asthma as a systemic and small airways disease

5. The Physiology of Small Airways

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZAP-AIRTMMICRONIZER: IMPACT ON NEBULIZED SALBUTAMOL SULPHATE AND IPRATROPIUM BROMIDE PARTICLE SIZE;International Journal of Applied Pharmaceutics;2024-09-07

2. Understanding the role of swirling flow in dry powder inhalers: Implications for design considerations and pulmonary delivery;Journal of Controlled Release;2024-09

3. The effects of airway disease on the deposition of inhaled drugs;Expert Opinion on Drug Delivery;2024-08-19

4. Assessing Inhaled Corticosteroid Adherence and Responsiveness in Severe Asthma Using Beclometasone Dipropionate/Formoterol NEXThaler Dose-Counting and Nitric Oxide Monitoring;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

5. Comparative study of the inhalation parameters of COPD patients through NEXThaler® and Ellipta® dry powder inhalers;Respiratory Medicine;2024-04